过度饮酒会减弱人类中枢动脉对西格玛受体-1连接体的响应能力
Patricia Zamora Diaz1,2, Tram Q Le1,2, Laura Hurtado Osorio1,2
1Department of Molecular Pharmacology & Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida, United States.
American journal of physiology. Heart and circulatory physiology
|December 1, 2025
概括
西格玛受体会影响人体动脉收缩,但大量饮酒会降低西格玛受体-1的表达,从而损害这种效应. 这突出了酒精.
科学领域:
- 药理学和生理学 药理学和生理学
- 血管生物学 血管生物学
- 神经科学是一个神经科学.
背景情况:
- 西格玛受体与血压调节有关.
- 西格玛受体,动脉和酒精消费之间的相互作用尚未得到充分理解.
研究的目的:
- 为了研究西格玛受体调节对人类中枢动脉中烯酸诱导的收缩的影响.
- 探索器官捐赠者的酒精使用史对这种相互作用的影响.
- 为了检查与酒精消费相关的西格玛受体-1表达.
主要方法:
- 电线肌图被用来评估烯诱导的动脉收缩.
- 实验中使用西格玛受体激动剂 (PRE-084) 和对抗剂 (BD-1047,SM-21) 进行了实验.
- 自动毛细管电泳分析了西格玛受体-1蛋白水平.
主要成果:
- 西格玛受体激动剂PRE-084将非/轻度和中度饮酒者,但不是重度饮酒者在动脉中的基度-反应曲线向下移动.
- 西格玛受体-1抗剂BD-1047在非/轻度和中度饮酒者中向上移动曲线,但不是重度饮酒者.
- 与其他群体相比,沉重饮酒者的动脉中西格玛受体-1蛋白水平明显较低.
结论:
- 人体动脉中的西格玛受体可能会促进放松,但这种功能因大量饮酒而受到损害.
- 在大量饮酒者中降低了西格玛受体-1表达,损害了其调节动脉收缩的能力.
- 西格玛受体-1在人体动脉律中起作用,由酒精使用调节.
相关概念视频
CNS Depressants: Alcohol and Nicotine
978
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
978
Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Opioid Receptors: Overview
3.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.8K


